Keith Vosseller - Publications

Affiliations: 
Biochemistry Drexel University College of Medicine, Philadelphia, PA, United States 
Area:
Molecular Biology, Neuroscience Biology

33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Ma Z, Chalkley RJ, Vosseller K. Hyper-O-GlcNAcylation activates NF-κB signaling through interplay with phosphorylation and acetylation. The Journal of Biological Chemistry. PMID 28416608 DOI: 10.1074/Jbc.M116.766568  0.591
2014 Ma Z, Vosseller K. Cancer metabolism and elevated O-GlcNAc in oncogenic signaling. The Journal of Biological Chemistry. 289: 34457-65. PMID 25336642 DOI: 10.1074/Jbc.R114.577718  0.626
2014 Skorobogatko Y, Landicho A, Chalkley RJ, Kossenkov AV, Gallo G, Vosseller K. O-linked β-N-acetylglucosamine (O-GlcNAc) site thr-87 regulates synapsin I localization to synapses and size of the reserve pool of synaptic vesicles. The Journal of Biological Chemistry. 289: 3602-12. PMID 24280219 DOI: 10.1074/Jbc.M113.512814  0.803
2013 Ma Z, Vosseller K. O-GlcNAc in cancer biology. Amino Acids. 45: 719-33. PMID 23836420 DOI: 10.1007/S00726-013-1543-8  0.571
2013 Ma Z, Vocadlo DJ, Vosseller K. Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells. The Journal of Biological Chemistry. 288: 15121-30. PMID 23592772 DOI: 10.1074/Jbc.M113.470047  0.627
2013 Ma ZY, Skorobogatko Y, Vosseller K. Tandem lectin weak affinity chromatography for glycoprotein enrichment. Methods in Molecular Biology (Clifton, N.J.). 951: 21-31. PMID 23296521 DOI: 10.1007/978-1-62703-146-2_2  0.793
2012 Yuzwa SA, Shan X, Macauley MS, Clark T, Skorobogatko Y, Vosseller K, Vocadlo DJ. Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation. Nature Chemical Biology. 8: 393-9. PMID 22366723 DOI: 10.1038/Nchembio.797  0.793
2012 Lynch TP, Ferrer CM, Jackson SR, Shahriari KS, Vosseller K, Reginato MJ. Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis. The Journal of Biological Chemistry. 287: 11070-81. PMID 22275356 DOI: 10.1074/Jbc.M111.302547  0.511
2011 Zachara NE, Vosseller K, Hart GW. Detection and analysis of proteins modified by O-linked N-acetylglucosamine. Current Protocols in Protein Science / Editorial Board, John E. Coligan ... [Et Al.]. Unit12.8. PMID 22045558 DOI: 10.1002/0471140864.Ps1208S66  0.679
2011 Zachara NE, Vosseller K, Hart GW. Detection and analysis of proteins modified by O-linked N-acetylglucosamine. Current Protocols in Molecular Biology / Edited by Frederick M. Ausubel ... [Et Al.]. Unit 17.6. PMID 21732316 DOI: 10.1002/0471142727.mb1706s95  0.625
2011 Yuzwa SA, Yadav AK, Skorobogatko Y, Clark T, Vosseller K, Vocadlo DJ. Mapping O-GlcNAc modification sites on tau and generation of a site-specific O-GlcNAc tau antibody. Amino Acids. 40: 857-68. PMID 20706749 DOI: 10.1007/S00726-010-0705-1  0.793
2011 Skorobogatko YV, Deuso J, Adolf-Bryfogle J, Adolf-Bergfoyle J, Nowak MG, Gong Y, Lippa CF, Vosseller K. Human Alzheimer's disease synaptic O-GlcNAc site mapping and iTRAQ expression proteomics with ion trap mass spectrometry. Amino Acids. 40: 765-79. PMID 20563614 DOI: 10.1007/S00726-010-0645-9  0.789
2011 Lynch TP, Jackson SR, Shahriari KS, Ferrer CM, Lazarus M, Walker S, Vosseller K, Reginato MJ. Abstract 1267: Metabolic sensor O-GlcNAc Transferase is a novel regulator of prostate cancer invasion and angiogenesis via regulation of FoxM1 Cancer Research. 71: 1267-1267. DOI: 10.1158/1538-7445.Am2011-1267  0.446
2011 Skorobogatko YV, Deuso J, Adolf-Bryfogle J, Nowak MG, Gong Y, Lippa CF, Vosseller K. Erratum to: Human Alzheimer’s disease synaptic O-GlcNAc site mapping and iTRAQ expression proteomics with ion trap mass spectrometry Amino Acids. 42: 2529-2529. DOI: 10.1007/s00726-011-0896-0  0.462
2010 Vosseller K. O-GlcNAc and aging: C. elegans as a genetic model to test O-GlcNAc roles in type II diabetic insulin resistance. Aging. 2: 749-51. PMID 21068466  0.414
2010 Caldwell SA, Jackson SR, Shahriari KS, Lynch TP, Sethi G, Walker S, Vosseller K, Reginato MJ. Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1. Oncogene. 29: 2831-42. PMID 20190804 DOI: 10.1038/Onc.2010.41  0.524
2009 Francisco H, Kollins K, Varghis N, Vocadlo D, Vosseller K, Gallo G. O-GLcNAc post-translational modifications regulate the entry of neurons into an axon branching program. Developmental Neurobiology. 69: 162-73. PMID 19086029 DOI: 10.1002/Dneu.20695  0.574
2009 Tallent MK, Varghis N, Skorobogatko Y, Hernandez-Cuebas L, Whelan K, Vocadlo DJ, Vosseller K. In vivo modulation of O-GlcNAc levels regulates hippocampal synaptic plasticity through interplay with phosphorylation. The Journal of Biological Chemistry. 284: 174-81. PMID 19004831 DOI: 10.1074/Jbc.M807431200  0.802
2009 Vosseller K, Skorobogatko Y, Bryfogle JA, LaFerla FM, Vocadlo DJ, Tallent M. P4-228: O-GlcNAc regulation of hippocampal synaptic plasticity in wild type and 3xTg-AD mice Alzheimer's & Dementia. 5: P497-P497. DOI: 10.1016/J.Jalz.2009.04.694  0.761
2008 Chalkley RJ, Wells L, Vosseller K. Chapter 15 O-GlcNAc Proteomics: Mass Spectrometric Analysis of O-GlcNAc Modifications on Proteins Comprehensive Analytical Chemistry. 52. DOI: 10.1016/S0166-526X(08)00215-8  0.684
2007 Vosseller K. Proteomics of Alzheimer's disease: Unveiling protein dysregulation in complex neuronal systems. Proteomics. Clinical Applications. 1: 1351-61. PMID 21136635 DOI: 10.1002/Prca.200700323  0.386
2007 Akimoto Y, Hart GW, Wells L, Vosseller K, Yamamoto K, Munetomo E, Ohara-Imaizumi M, Nishiwaki C, Nagamatsu S, Hirano H, Kawakami H. Elevation of the post-translational modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats. Glycobiology. 17: 127-40. PMID 17095531 DOI: 10.1093/Glycob/Cwl067  0.607
2006 Vosseller K, Trinidad JC, Chalkley RJ, Specht CG, Thalhammer A, Lynn AJ, Snedecor JO, Guan S, Medzihradszky KF, Maltby DA, Schoepfer R, Burlingame AL. O-linked N-acetylglucosamine proteomics of postsynaptic density preparations using lectin weak affinity chromatography and mass spectrometry. Molecular & Cellular Proteomics : McP. 5: 923-34. PMID 16452088 DOI: 10.1074/Mcp.T500040-Mcp200  0.698
2005 Slawson C, Zachara NE, Vosseller K, Cheung WD, Lane MD, Hart GW. Perturbations in O-linked beta-N-acetylglucosamine protein modification cause severe defects in mitotic progression and cytokinesis. The Journal of Biological Chemistry. 280: 32944-56. PMID 16027160 DOI: 10.1074/Jbc.M503396200  0.661
2005 Vosseller K, Hansen KC, Chalkley RJ, Trinidad JC, Wells L, Hart GW, Burlingame AL. Quantitative analysis of both protein expression and serine / threonine post-translational modifications through stable isotope labeling with dithiothreitol. Proteomics. 5: 388-98. PMID 15648052 DOI: 10.1002/Pmic.200401066  0.636
2003 Wells L, Vosseller K, Hart GW. A role for N-acetylglucosamine as a nutrient sensor and mediator of insulin resistance. Cellular and Molecular Life Sciences : Cmls. 60: 222-8. PMID 12678487 DOI: 10.1007/S000180300017  0.371
2002 Vosseller K, Sakabe K, Wells L, Hart GW. Diverse regulation of protein function by O-GlcNAc: a nuclear and cytoplasmic carbohydrate post-translational modification. Current Opinion in Chemical Biology. 6: 851-7. PMID 12470741 DOI: 10.1016/S1367-5931(02)00384-8  0.667
2002 Wells L, Vosseller K, Cole RN, Cronshaw JM, Matunis MJ, Hart GW. Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-translational modifications. Molecular & Cellular Proteomics : McP. 1: 791-804. PMID 12438562 DOI: 10.1074/Mcp.M200048-Mcp200  0.628
2002 Vosseller K, Wells L, Lane MD, Hart GW. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proceedings of the National Academy of Sciences of the United States of America. 99: 5313-8. PMID 11959983 DOI: 10.1073/Pnas.072072399  0.523
2002 Wells L, Gao Y, Mahoney JA, Vosseller K, Chen C, Rosen A, Hart GW. Dynamic O-glycosylation of nuclear and cytosolic proteins: further characterization of the nucleocytoplasmic beta-N-acetylglucosaminidase, O-GlcNAcase. The Journal of Biological Chemistry. 277: 1755-61. PMID 11788610 DOI: 10.1074/Jbc.M109656200  0.666
2001 Vosseller K, Wells L, Hart GW. Nucleocytoplasmic O-glycosylation: O-GlcNAc and functional proteomics. Biochimie. 83: 575-81. PMID 11522385 DOI: 10.1016/S0300-9084(01)01295-0  0.686
2001 Comer FI, Vosseller K, Wells L, Accavitti MA, Hart GW. Characterization of a mouse monoclonal antibody specific for O-linked N-acetylglucosamine Analytical Biochemistry. 293: 169-177. PMID 11399029 DOI: 10.1006/Abio.2001.5132  0.676
2001 Wells L, Vosseller K, Hart GW. Glycosylation of nucleocytoplasmic proteins: Signal transduction and O-GlcNAc Science. 291: 2376-2378. PMID 11269319 DOI: 10.1126/Science.1058714  0.694
Show low-probability matches.